Lantus not riskier than insulin: study

(Reuters) UPDATED 2009-07-06

A new study indicates that the diabetes drug Lantus is no more likely to cause diabetic retinopathy than insulin. The 5-year study on Lantus versus NPH insulin showed similar rates of safety and retinopathy in both groups, despite an earlier study which linked Lantus to the eye disease. Read full story >

See all Diabetes News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Lantus not riskier than insulin: study

People who read this also read...

What the community is saying...

Another Medication for Type 2 Diabetes

Dr. Bill Quick